Explore Business Standard
Ivf
Nova Fertility Clinic here on Thursday announced plans to integrate Artificial Intelligence into its IVF labs to improve precision in embryo selection, a critical aspect of fertility treatment. Improved precision can also reduce the number of embryos needed for transfer, addressing ethical concerns related to multiple pregnancies, said Shobhit Agarwal, CEO of Nova Fertility Clinic. According to a press release, the chain is partnering with South Korea's AI technology firm Kai Health to implement Vita Embryo, an AI-based embryo assessment system. Hyejun Lee, CEO of Kai Health, said, Our research indicates that AI intervention increases the precision of embryo selection by 12 per cent. Vita Embryo will be rolled out across 120 Nova Fertility Clinics in 65 cities, the release added.
Fertility services provider Indira IVF Hospital Ltd has confidentially filed draft papers with markets regulator Sebi to raise funds through an initial public offering (IPO), according to a public announcement on Wednesday. The development comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favourable demographics. In a public announcement, Indira IVF stated that it has submitted "the pre-filed draft red herring prospectus with Sebi and the stock exchanges... in relation to the proposed initial public offering of its equity shares on the main board of the stock exchanges." The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO). Meanwhile, market sources said Gaudium IVF and Women Healt
Fertility clinic chain Indira IVF Hospital has withdrawn its draft IPO papers, which were filed through the confidential route, an update with markets regulator Sebi showed on Tuesday. The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO). The preliminary IPO papers were received by the Securities and Exchange Board of India (Sebi) on February 13, however, "draft offer document (was) withdrawn on March 19, 2025" by the company without disclosing any reasons. Last week, PhysicsWallah joined the league of a handful of companies that took confidential filing routes for its IPO. In 2024, food delivery giant Swiggy and supermart major Vishal Mega Mart successfully floated their respective initial share sales after making confidential filings. Before this, online hotel aggregator OYO took the .
President Donald Trump has signed an executive order meant to expand access to and reduce costs of in vitro fertilisation and issued a presidential memorandum calling for radical transparency requirements from the government, which he suggested could reduce wasteful spending. On the campaign trail, Trump called for universal coverage of IVF treatment after his Supreme Court nominees helped to overturn Roe v. Wade, leading to a wave of restrictions in Republican-led states, including some that have threatened access to IVF by trying to define life as beginning at conception. Trump, who was at his Florida residence and club, Mar-a-Lago, on Tuesday, also signed another executive order as well as a presidential memorandum. The second executive order outlined the oversight functions of the Office of Management and Budget, while the memo requires the government to detail the waste, fraud and abuse that's found as the Department of Government Efficiency, overseen by Tesla CEO Elon Musk, ...
Infertility is not just a medical condition but a crisis fuelled by lifestyle choices, with infertility rates soaring particularly in lower-income groups and tier 2 and 3 cities where access to healthcare is limited, a top IVF specialist said. Dr Ajay Murdia, the man behind one of India's largest fertility chain, Indira IVF, said while advancements in assisted reproductive technologies like In Vitro Fertilization (IVF) offer hope, it is a reality that the underprivileged who are hit hard. "Infertility rates are soaring, particularly in lower-income and tier 2 and 3 cities, where access to healthcare, nutrition, and education is limited," Dr Murdia, founder and chairman of Indira IVF, told PTI. "Infertility is no longer just a medical issue; it's a crisis fuelled by lifestyle choices that hit the underprivileged hardest. Without action, even advancements like IVF will remain out of reach for many," he said. Lifestyle factors such as obesity, poor diet, smoking, and chronic stress, .
Hormonal issues, increasing substance use, and changing lifestyle are leading to an increase in infertility in India, which may irreversibly altar India's population dynamics, potentially leading to an ageing crisis, Dr Ajay Murdia, the man behind India's one of the largest fertility chain, Indira IVF, has said. Talking to PTI ahead of the World IVF Day on July 25, Dr Murdia said that India stands at a critical crossroads, facing an unprecedented infertility crisis that threatens not only millions of families but the country's future demographic balance. "According to some estimates, about 27.5 million married couples are actively trying to conceive and are suffering from infertility. But only about 275,000 IVF cycles are performed every year," he said. "This silent epidemic, affecting one in six couples, is rapidly evolving into a national emergency with far-reaching consequences for India's societal structure and economic prospects," Murdia, Founder and Chairman of Indira IVF, ...